SHARDACROP

Sharda Cropchem Share Price

 

 

Invest in Sharda Cropchem with 2.62X leverage

Invest with MTF

Performance

  • Low
  • ₹788
  • High
  • ₹803
  • 52 Week Low
  • ₹452
  • 52 Week High
  • ₹1,181
  • Open Price₹0
  • Previous Close₹0
  • Volume
  • 50 DMA₹855.48
  • 100 DMA₹849.97
  • 200 DMA₹808.97

Investment Returns

  • Over 1 Month -11.95%
  • Over 3 Month -3.04%
  • Over 6 Month -3.96%
  • Over 1 Year + 4.78%

Smart Investing Starts Here Start SIP with Sharda Cropchem for Steady Growth!

Invest Now

Sharda Cropchem Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Sharda Cropchem Financials

Sharda Cropchem Technicals

EMA & SMA

Current Price
₹795.05
-2.6 (-0.33%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹851.05
  • 50 Day
  • ₹855.48
  • 100 Day
  • ₹849.97
  • 200 Day
  • ₹808.97

Resistance and Support

801.88 Pivot Speed
  • R3 835.77
  • R2 825.88
  • R1 811.77
  • S1 787.77
  • S2 777.88
  • S3 763.77

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Sharda Cropchem is a global agrochemicals company specializing in crop protection products, including herbicides, insecticides, and fungicides. It operates in over 80 countries, supplying generic agrochemicals, biocides, and conveyor belts to enhance agricultural productivity.

Sharda Cropchem has an operating revenue of Rs. 4,671.78 Cr. on a trailing 12-month basis. An annual revenue growth of 36% is outstanding, Pre-tax margin of 9% is okay, ROE of 12% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 39 which is a POOR score indicating inconsistency in earnings, a RS Rating of 80 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 110 indicates it belongs to a poor industry group of Chemicals-Agricultural and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Sharda Cropchem Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-10-30 Quarterly Results
2025-07-25 Quarterly Results
2025-05-14 Audited Results & Final Dividend
2025-01-24 Quarterly Results & Interim Dividend
2024-10-25 Quarterly Results
Date Purpose Remarks
2025-08-07 FINAL Rs.6.00 per share(60%)Final Dividend
2025-02-06 INTERIM Rs.3.00 per share(30%)Interim Dividend
2024-08-02 FINAL Rs.3.00 per share(30%)Final Dividend
2023-08-01 FINAL Rs.3.00 per share(30%)Final Dividend
2023-02-07 INTERIM Rs.3.00 per share(30%)Interim Dividend
View Sharda Cropchem Dividend History Arrow

Sharda Cropchem F&O

Sharda Cropchem Shareholding Pattern

74.82%
9.51%
4.2%
8.24%
3.23%

About Sharda Cropchem

  • NSE Symbol
  • SHARDACROP
  • BSE Symbol
  • 538666
  • Chairman & Managing Director
  • Mr. Ramprakash V Bubna
  • ISIN
  • INE221J01015

Similar Stocks to Sharda Cropchem

Sharda Cropchem FAQs

Sharda Cropchem share price is ₹795 As on 12 January, 2026 | 09:54

The Market Cap of Sharda Cropchem is ₹7173 Cr As on 12 January, 2026 | 09:54

The P/E ratio of Sharda Cropchem is 15.9 As on 12 January, 2026 | 09:54

The PB ratio of Sharda Cropchem is 2.7 As on 12 January, 2026 | 09:54

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23